The main goal of the Survey Research Core (SRC), located at the AMC Cancer Research Center, is to provide technical assistance and services to UCCC members in collecting research data, with specialized expertise in computer-assisted telephone interviews (CATI). The SRC collaborates in testing the effectiveness of cancer related health education and behavioral interventions delivered by telephone. Since its inception as a UCCC Core resource in the Year 2000, the SRC has shown sustained growth in utilization, providing support to 20 peer-reviewed cancer-related studies conducted by 12 different Principal Investigators affiliated with the UCCC. In these studies the SRC has conducted over 26,000 cancer-related telephone interviews. The number of cancer-related interviews completed by the SRC in Year 2004 exceeded 10,000, representing a 14-fold increase in utilization compared to the Year 2000. In the current operating budget the SRC gets 28% of its funding from the UCCC as a core resource, 55% from grants and contracts, and 17% from other UCCC institutional resources (Cancer Center gift funds and institutional support from AMC, a Consortium Cancer Center member institution). UCCC core funds provide partial support for consultation services, management, and oversight of this resource. All interviewer positions are 100% funded by grants and contracts. Future plans include: 1. expanding utilization of the SRC by UCCC members across a broader range of program areas (e.g. by using the SRC to conduct follow-up of patients in clinical trials) 2. using the SRC to test telephone education and counseling interventions across the full spectrum of cancer prevention and control 3. using the SRC to develop and test telephone-delivered patient navigation, support and referral interventions 4. expanding SRC capacity to conduct web-based surveys and interventions.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA046934-25S2
Application #
8710582
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-02-01
Budget End
2014-01-31
Support Year
25
Fiscal Year
2013
Total Cost
$961
Indirect Cost
$339
Name
University of Colorado Denver
Department
Type
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Saichaemchan, S; Ariyawutyakorn, W; Varella-Garcia, M (2016) Fibroblast Growth Factor Receptors: From the Oncogenic Pathway to Targeted Therapy. Curr Mol Med 16:40-62
Gillen, Austin E; Yamamoto, Tomomi M; Kline, Enos et al. (2016) Improvements to the HITS-CLIP protocol eliminate widespread mispriming artifacts. BMC Genomics 17:338
Justice, Cristina M; Bishop, Kevin; Carrington, Blake et al. (2016) Evaluation of IRX Genes and Conserved Noncoding Elements in a Region on 5p13.3 Linked to Families with Familial Idiopathic Scoliosis and Kyphosis. G3 (Bethesda) 6:1707-12
Eckwahl, Matthew J; Arnion, Helene; Kharytonchyk, Siarhei et al. (2016) Analysis of the human immunodeficiency virus-1 RNA packageome. RNA 22:1228-38
Iguchi, Nao; Malykhina, Anna P; Wilcox, Duncan T (2016) Inhibition of HIF Reduces Bladder Hypertrophy and Improves Bladder Function in Murine Model of Partial Bladder Outlet Obstruction. J Urol 195:1250-6
Seedorf, Gregory; Metoxen, Alexander J; Rock, Robert et al. (2016) Hepatocyte growth factor as a downstream mediator of vascular endothelial growth factor-dependent preservation of growth in the developing lung. Am J Physiol Lung Cell Mol Physiol 310:L1098-110
Agarwal, Neeraj; Dancik, Garrett M; Goodspeed, Andrew et al. (2016) GON4L Drives Cancer Growth through a YY1-Androgen Receptor-CD24 Axis. Cancer Res 76:5175-85
Helfrich, Barbara A; Kim, Jihye; Gao, Dexiang et al. (2016) Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In Vivo. Mol Cancer Ther 15:2314-2322
Munson, Daniel J; Egelston, Colt A; Chiotti, Kami E et al. (2016) Identification of shared TCR sequences from T cells in human breast cancer using emulsion RT-PCR. Proc Natl Acad Sci U S A 113:8272-7
Scott, Aaron J; Lieu, Christopher H; Messersmith, Wells A (2016) Therapeutic Approaches to RAS Mutation. Cancer J 22:165-74

Showing the most recent 10 out of 1302 publications